Evidence map›Paper›PMID 28839115›Full record

ArticleG3 (Bethesda, Md.)2017

Genome-Scale Genetic Interactions and Cell Imaging Confirm Cytokinesis as Deleterious to Transient Topoisomerase II Deficiency in

Cristina Ramos-Pérez, Jessel Ayra-Plasencia, Emiliano Matos-Perdomo, Michael Lisby, Grant W Brown, Félix Machín

Open access · goldAbstract read
In one paragraph

Article in G3 (Bethesda, Md.), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Yeast Tools for Studying Type II Topoisomerases in Budding Yeast.Methods in molecular biology (Clifton, N.J.) · 2025
    Article
  2. Article
  3. The Multiple Roles of the Cdc14 Phosphatase in Cell Cycle Control.International journal of molecular sciences · 2020
    Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 3 countries.

Cristina Ramos-PérezUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.
Jessel Ayra-PlasenciaUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.ORCID 0000-0003-1052-4214
Emiliano Matos-PerdomoUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain.ORCID 0000-0001-9783-3591
Michael LisbyDepartment of Biology, University of Copenhagen, DK-2200, Denmark.ORCID 0000-0002-4830-5247
Grant W BrownDepartment of Biochemistry and Donnelly Centre, University of Toronto, Ontario M5S3E1, Canada.ORCID 0000-0002-9002-5003
Félix MachínUnidad de Investigación, Hospital Universitario Nuestra Señora de Candelaria, 38010 Santa Cruz de Tenerife, Spain fmachin@funcanis.es.ORCID 0000-0003-4559-7798
Universidad de La Laguna · ESHospital Universitario Nuestra Señora de Candelaria · ESUniversity of Copenhagen · DKUniversity of Toronto · CA

Funding

CIHR MOP-79368
6 · The paper itself

Abstract

Topoisomerase II (Top2) is an essential protein that resolves DNA catenations. When Top2 is inactivated, mitotic catastrophe results from massive entanglement of chromosomes. Top2 is also the target of many first-line anticancer drugs, the so-called Top2 poisons. Often, tumors become resistant to these drugs by acquiring hypomorphic mutations in the genes encoding Top2 Here, we have compared the cell cycle and nuclear segregation of two coisogenic

Indexed as

CytokinesisDNA Topoisomerases, Type IIMicroscopy, FluorescenceSaccharomyces cerevisiaeSingle-Cell AnalysisDNA Topoisomerases, Type IIanaphase bridgesCdc14cytokinesismitotic exit networkplasma membrane abscissionsynthetic genetic array analysistop2-4 and top2-5topoisomerase II

Identifiers

PMID28839115
PMCPMC5633387
OpenAlexW2747489190

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.